RNA-Seq Accurately Identifies Cancer Biomarker Signatures to Distinguish Tissue of Origin()

Metastatic cancer of unknown primary (CUP) accounts for up to 5% of all new cancer cases, with a 5-year survival rate of only 10%. Accurate identification of tissue of origin would allow for directed, personalized therapies to improve clinical outcomes. Our objective was to use transcriptome sequenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Iris H., Shi, Yang, Jiang, Hui, Kumar-Sinha, Chandan, Chinnaiyan, Arul M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240918/
https://www.ncbi.nlm.nih.gov/pubmed/25425966
http://dx.doi.org/10.1016/j.neo.2014.09.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240918/
https://www.ncbi.nlm.nih.gov/pubmed/25425966
http://dx.doi.org/10.1016/j.neo.2014.09.007

Ejemplares similares